Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
NCT02775643 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-11-10
Summary
This is an observational, non-therapeutic study to collect clinical and molecular information of pediatric patients with childhood melanocytic lesions.
PRIMARY OBJECTIVE: To perform a comprehensive molecular analysis of samples either from paraffin embedded and/or frozen tissue from patients with pediatric melanocytic lesions (including melanoma, spitzoid melanoma, congenital melanoma, melanoma arising in giant nevi).
SECONDARY OBJECTIVE: To collect minimal information on patients treated with adjuvant or systemic therapies according to National Comprehensive Cancer Network (NCCN) guidelines.
Conditions
Sponsors & Collaborators
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Alberto Pappo, MD · St. Jude Children's Research Hospital
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2031-05-31
- Completion
- 2041-05-31
Countries
- United States
Study Locations
More Related Trials
-
The Role of Melanocyte in Basal Cell Carcinoma
NCT02576769 ·Status: UNKNOWN
-
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
NCT06680323 ·Status: RECRUITING
-
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
NCT05446155 ·Status: RECRUITING
-
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
NCT00525031 ·Status: COMPLETED ·Phase: PHASE2
-
Atypical MOLes and Melanoma Early Detection Study (MoleMed)
NCT04353050 ·Status: UNKNOWN ·Phase: NA
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
NCT02056522 ·Status: COMPLETED
-
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
NCT05426239 ·Status: COMPLETED
-
Multicenter Selective Lymphadenectomy Trial (MSLT)
NCT00275496 ·Status: COMPLETED ·Phase: PHASE3
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin
NCT01085396 ·Status: TERMINATED
-
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
NCT01511913 ·Status: COMPLETED
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT00040352 ·Status: RECRUITING
-
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
NCT01990859 ·Status: COMPLETED ·Phase: PHASE2
-
Role of SLURP-1 in Melanoma and Melanoma Stem Cells
NCT01281722 ·Status: UNKNOWN
-
Reflectance Confocal Microscopy to Diagnose MM & LM
NCT03508297 ·Status: COMPLETED
-
Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab
NCT02600169 ·Status: COMPLETED
-
Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis
NCT05406466 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
NCT00796445 ·Status: TERMINATED ·Phase: PHASE3
-
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
NCT03165422 ·Status: COMPLETED
-
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
NCT00849407 ·Status: UNKNOWN
-
Long-term Data Collection for Subjects in MDX-010 Studies
NCT00928031 ·Status: COMPLETED
-
Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma
NCT01709162 ·Status: TERMINATED ·Phase: PHASE2